## High-throughput screening(HTS)

[TOC]

#### [1.Definition](#High-throughput screening(HTS))

High-throughput screening (HTS) is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Using robotics, data processing/control software, liquid handling devices, and sensitive detectors, high-throughput screening allows a researcher to quickly conduct millions of chemical, genetic, or pharmacological tests. Through this process one can rapidly identify active compounds, antibodies, or genes that modulate a particular biomolecular pathway. The results of these experiments provide starting points for drug design and for understanding the noninteraction or role of a particular location. (wiki)

![](C:\Users\å‡¤ç¾½ç©º\Desktop\ç»†èƒç”Ÿç‰©å­¦å°ç»„ä½œä¸š\å›¾ç‰‡åº“\1280px-Chemical_Genomics_Robot.jpg)

![](C:\Users\å‡¤ç¾½ç©º\Desktop\ç»†èƒç”Ÿç‰©å­¦å°ç»„ä½œä¸š\å›¾ç‰‡åº“\Robot_arm_handles_an_assay_plate.jpg)

é«˜é€šé‡ç­›é€‰ (HTS) æ˜¯ä¸€ç§ç§‘å­¦å®éªŒæ–¹æ³•ï¼Œå°¤å…¶ç”¨äºè¯ç‰©å‘ç°å¹¶ä¸ç”Ÿç‰©å­¦å’ŒåŒ–å­¦é¢†åŸŸç›¸å…³ã€‚ ä½¿ç”¨æœºå™¨äººã€æ•°æ®å¤„ç†/æ§åˆ¶è½¯ä»¶ã€æ¶²ä½“å¤„ç†è®¾å¤‡å’Œçµæ•çš„æ£€æµ‹å™¨ï¼Œé«˜é€šé‡ç­›é€‰ä½¿ç ”ç©¶äººå‘˜èƒ½å¤Ÿå¿«é€Ÿè¿›è¡Œæ•°ç™¾ä¸‡æ¬¡åŒ–å­¦ã€é—ä¼ æˆ–è¯ç†å­¦æµ‹è¯•ã€‚ é€šè¿‡è¿™ä¸€è¿‡ç¨‹ï¼Œäººä»¬å¯ä»¥å¿«é€Ÿè¯†åˆ«è°ƒèŠ‚ç‰¹å®šç”Ÿç‰©åˆ†å­é€”å¾„çš„æ´»æ€§åŒ–åˆç‰©ã€æŠ—ä½“æˆ–åŸºå› ã€‚ è¿™äº›å®éªŒçš„ç»“æœä¸ºè¯ç‰©è®¾è®¡å’Œç†è§£ç‰¹å®šä½ç½®çš„éç›¸äº’ä½œç”¨æˆ–ä½œç”¨æä¾›äº†èµ·ç‚¹ã€‚ 

High throughput screening (HTS) technology refers to experimental methods at the molecular and cellular levels as the basis, using microplates as the experimental tool carrier, performing the test process with an automated operating system, and collecting with sensitive and rapid detection equipment. The experimental result data is analyzed and processed by a computer, and tens of millions of samples are detected at the same time, and the corresponding database is obtained to support the operation of the technical system. It has the characteristics of trace, fast, sensitive and accurate. In short, a large amount of information can be obtained through one experiment, and valuable information can be found from it. ï¼ˆbaiduï¼‰

é«˜é€šé‡ç­›é€‰(High throughput screeningï¼ŒHTS)æŠ€æœ¯æ˜¯æŒ‡ä»¥åˆ†å­æ°´å¹³å’Œç»†èƒæ°´å¹³çš„å®éªŒæ–¹æ³•ä¸ºåŸºç¡€ï¼Œä»¥å¾®æ¿å½¢å¼ä½œä¸ºå®éªŒå·¥å…·è½½ä½“ï¼Œä»¥è‡ªåŠ¨åŒ–æ“ä½œç³»ç»Ÿæ‰§è¡Œè¯•éªŒè¿‡ç¨‹ï¼Œä»¥çµæ•å¿«é€Ÿçš„æ£€æµ‹ä»ªå™¨é‡‡é›†å®éªŒç»“æœæ•°æ®ï¼Œä»¥è®¡ç®—æœºåˆ†æå¤„ç†å®éªŒæ•°æ®ï¼Œåœ¨åŒä¸€æ—¶é—´æ£€æµ‹æ•°ä»¥åƒä¸‡çš„æ ·å“ï¼Œå¹¶ä»¥å¾—åˆ°çš„ç›¸åº”æ•°æ®åº“æ”¯æŒè¿è½¬çš„æŠ€æœ¯ä½“ç³»ï¼Œå®ƒå…·æœ‰å¾®é‡ã€å¿«é€Ÿã€çµæ•å’Œå‡†ç¡®ç­‰ç‰¹ç‚¹ã€‚ç®€è¨€ä¹‹å°±æ˜¯å¯ä»¥é€šè¿‡ä¸€æ¬¡å®éªŒè·å¾—å¤§é‡çš„ä¿¡æ¯ï¼Œå¹¶ä»ä¸­æ‰¾åˆ°æœ‰ä»·å€¼çš„ä¿¡æ¯ã€‚



#### [2.Challenges in Breeding Industrial Microorganismsï¼ˆå‰è¨€/å¼•æ–‡ï¼‰](#High-throughput screening(HTS))

Naturally isolated microorganisms can rarely be directly used for industrial-
scale production because of low yields and weak tolerance to harsh industrial conditions. Various
strategies have been developed to overcome these problems, including reconstructing cell facto-
ries through modifying the physiological functions of the microorganism at the gene level, and by
providing optimum environments for strain growth and product accumulation.

è‡ªç„¶åˆ†ç¦»çš„å¾®ç”Ÿç‰©å¾ˆå°‘èƒ½ç›´æ¥ç”¨äºå·¥ä¸šè§„æ¨¡ç”Ÿäº§ï¼Œå› ä¸ºäº§é‡ä½å’Œå¯¹æ¶åŠ£å·¥ä¸šæ¡ä»¶çš„è€å—åŠ›å·®ã€‚ä¸ºäº†å…‹æœè¿™äº›é—®é¢˜ï¼Œå·²ç»åˆ¶å®šäº†å„ç§ç­–ç•¥ï¼ŒåŒ…æ‹¬é€šè¿‡åœ¨åŸºå› æ°´å¹³ä¸Šä¿®æ”¹å¾®ç”Ÿç‰©çš„ç”Ÿç†åŠŸèƒ½ï¼Œä»¥åŠé€šè¿‡ä¸ºèŒæ ªç”Ÿé•¿å’Œäº§ç‰©ç§¯ç´¯æä¾›æœ€ä½³ç¯å¢ƒï¼Œé‡å»ºç»†èƒå·¥å‚

To increase the accumulation of target products, several random mutagenesis and rational
engineering approaches, including physical and chemical mutagenesis ,adaptive laboratory
evolution (ALE), and genetic and metabolic engineering[8,9], have been developed. It is
crucial to develop methods for rapidly screening microbial strains in a large library of mutants
because the probability of a beneficial mutation can be very low ($<1/10^5$). The efficiency of
conventional screening is significantly limited by low throughput and slow detection methods,
leading to high costs for screening large numbers of mutants . Therefore, HTS procedures
have been widely used to isolate high-producer microbial cell factories (Figure 1, Key Figure) 

ä¸ºäº†å¢åŠ ç›®æ ‡äº§ç‰©çš„ç§¯ç´¯ï¼Œå·²ç»å¼€å‘äº†å‡ ç§éšæœºçªå˜å’Œåˆç†çš„å·¥ç¨‹æ–¹æ³•ï¼ŒåŒ…æ‹¬ç‰©ç†å’ŒåŒ–å­¦çªå˜ã€é€‚åº”æ€§å®éªŒå®¤è¿›åŒ–(ALE)[7]å’Œé—ä¼ å’Œä»£è°¢å·¥ç¨‹å­¦ã€‚åœ¨å¤§é‡çš„çªå˜ä½“åº“ä¸­å¿«é€Ÿç­›é€‰å¾®ç”Ÿç‰©èŒæ ªæ˜¯è‡³å…³é‡è¦çš„ï¼Œå› ä¸ºæœ‰ç›Šçªå˜çš„æ¦‚ç‡éå¸¸ä½($<1/10^5$)ã€‚å¸¸è§„ç­›é€‰çš„æ•ˆç‡å—åˆ°ä½é€šé‡å’Œç¼“æ…¢æ£€æµ‹æ–¹æ³•çš„ä¸¥é‡é™åˆ¶ï¼Œå¯¼è‡´ç­›é€‰å¤§é‡çªå˜ä½“çš„æˆæœ¬é«˜ã€‚å› æ­¤ï¼ŒHTS  è¢«å¹¿æ³›ç”¨äºåˆ†ç¦»é«˜äº§å¾®ç”Ÿç‰©ç»†èƒå·¥å‚(å›¾1ï¼Œkey figure)



â€‹		**Cell Factories for Product Synthesis Facilitated by High-throughput Screening(HTS)**



![ä½ ](C:\Users\å‡¤ç¾½ç©º\Desktop\ç»†èƒç”Ÿç‰©å­¦å°ç»„ä½œä¸š\å›¾ç‰‡åº“\cell_factory .jpg)



figure 1 : Based on cell factories, substrates (ethanol, glucose, starch, etc.) are converted into a series of products (amino acids, organic acids, alcohols, vitamins,flavonoids, terpenoids, etc.). Common microbial cell factories include bacteria, yeasts, actinomycetes, and fungi. The performance of these microorganisms in accumulating target products can be improved by HTS for intracellular products based on fluorescence-activated cell sorting (FACS) and screening of extracellular
products based on microfluidics.

åŸºäºç»†èƒå·¥å‚ï¼Œåº•ç‰©(ä¹™é†‡ï¼Œè‘¡è„ç³–ï¼Œæ·€ç²‰ç­‰)è¢«è½¬åŒ–ä¸ºä¸€ç³»åˆ—äº§å“(æ°¨åŸºé…¸ï¼Œæœ‰æœºé…¸ï¼Œé†‡ï¼Œç»´ç”Ÿç´ ï¼Œé»„é…®ç±»ï¼Œèœç±»ç­‰)ã€‚å¸¸è§çš„å¾®ç”Ÿç‰©ç»†èƒå·¥å‚åŒ…æ‹¬==ç»†èŒã€é…µæ¯èŒã€æ”¾çº¿èŒå’ŒçœŸèŒ==(ä»å·¦å¾€å³)ã€‚åˆ©ç”¨æµå¼ç»†èƒè§å…‰åˆ†é€‰æŠ€æœ¯å’ŒåŸºäºå¾®æµæ§æŠ€æœ¯çš„ç»†èƒå¤–äº§ç‰©ç­›é€‰æŠ€æœ¯è¿›è¡Œç»†èƒå†…äº§ç‰©çš„ç­›é€‰ï¼Œå¯ä»¥æé«˜è¿™äº›å¾®ç”Ÿç‰©ç§¯ç´¯é¶äº§ç‰©çš„æ€§èƒ½ã€‚

so how to select industrial microorangisms?

Two aspects need to be carefully considered in the selection of industrial microorganisms:
how to **expand the scope of the screening** (**generation of a diverse screening library and enabling**
**technologies for expanding the search range**), and how to **enhance the recognition of**
**target products** (**analytical methods to detect specific target products biosynthesized from**
**mutated or engineered microorganisms**)

åœ¨é€‰æ‹©å·¥ä¸šå¾®ç”Ÿç‰©æ—¶ï¼Œéœ€è¦è®¤çœŸè€ƒè™‘ä¸¤ä¸ªæ–¹é¢:==å¦‚ä½•æ‰©å¤§ç­›é€‰èŒƒå›´==(ç”Ÿæˆå¤šæ ·åŒ–çš„ç­›é€‰åº“å’Œæ‰©å¤§æœç´¢èŒƒå›´çš„ä½¿èƒ½æŠ€æœ¯)  ï¼Œä»¥åŠ==å¦‚ä½•æé«˜å¯¹ç›®æ ‡äº§å“çš„è¯†åˆ«==(æ£€æµ‹ç”±çªå˜æˆ–å·¥ç¨‹å¾®ç”Ÿç‰©åˆæˆçš„ç‰¹å®šç›®æ ‡äº§å“çš„åˆ†ææ–¹æ³•)ã€‚

This review mainly focuses on current strategies and future perspectives of HTS procedures ranging from mutant library generation, enabling technologies for expanding the search range, to the analytical methods used for HTS. Some of the most recent advances and benefits of HTS technology are summa-
rized in Box 1.

æœ¬æ–‡ä¸»è¦ä»‹ç»HTSæŠ€æœ¯çš„ç ”ç©¶ç°çŠ¶å’Œå‘å±•å‰æ™¯ï¼ŒåŒ…æ‹¬çªå˜ä½“åº“çš„å»ºç«‹ã€æ‰©å¤§æœç´¢èŒƒå›´çš„ä½¿èƒ½æŠ€æœ¯ï¼Œä»¥åŠç”¨äºHTSçš„åˆ†ææ–¹æ³•ç­‰ã€‚Box 1æ€»ç»“äº†HTSæŠ€æœ¯çš„ä¸€äº›æœ€æ–°è¿›å±•å’Œä¼˜ç‚¹



![](C:\Users\å‡¤ç¾½ç©º\Desktop\ç»†èƒç”Ÿç‰©å­¦å°ç»„ä½œä¸š\å›¾ç‰‡åº“\Advantafes of HTS technology.png)

Box1ï¼š

HTSåœ¨åˆ†å­å’Œç»†èƒå±‚é¢ä¸Šå·²ç»å¾ˆæˆç†Ÿäº†ã€‚å®ƒå°†è‡ªåŠ¨åŒ–å’Œå¾®å®šé‡å®éªŒä¸å¤§è§„æ¨¡æ•°æ®åˆ†æç›¸ç»“åˆã€‚è‡ªåŠ¨åŒ–æ­¥éª¤åŒ…æ‹¬é‡‡æ ·ã€å°†æ ·å“ç¨€é‡Šåˆ°åˆé€‚çš„æ£€æµ‹èŒƒå›´ã€è½¬ç§»æ ·å“å’Œæ˜¾è‰²å‰‚ã€æ··åˆæ ·å“ã€æ´—æ¶¤ç»†èƒã€æ˜¾è‰²ååº”æˆ–é…¶è”ååº”ã€é¢œè‰²æˆ–è§å…‰æ£€æµ‹ã€æ•°æ®åˆ†æå’Œæ”¹è‰¯èŒæ ªçš„æ”¶é›†ã€‚HTSæœ€æ—©æ˜¯åœ¨20ä¸–çºª90å¹´ä»£åˆå¼€å‘å‡ºæ¥çš„ï¼Œéšåäº§é‡çš„å¢åŠ è¿›ä¸€æ­¥åˆºæ¿€äº†æ£€æµ‹å°å‹åŒ–ã€è‡ªåŠ¨åŒ–å’Œæœºå™¨äººæŠ€æœ¯çš„å‘å±•ã€‚HTSç°å·²æ¼”å˜ä¸ºè¶…é€šé‡ç­›é€‰(UHTS)ã€‚HTSæŠ€æœ¯å·²æˆä¸ºä¸€ç§å¸¸è§„çš„å®éªŒå®¤æŠ€æœ¯ï¼Œå¹¿æ³›åº”ç”¨äºå·¥ä¸šç”Ÿç‰©æŠ€æœ¯çš„åŸºç¡€ç ”ç©¶å’Œåº”ç”¨ç ”ç©¶ã€‚éšç€èŒè½æ‹¾å–å™¨ã€æ¶²ä½“å¤„ç†ç³»ç»Ÿã€æµå¼ç»†èƒè§å…‰åˆ†é€‰(FACS)å’Œæ¶²æ»´å¾®æµä½“ç­‰æ–°è®¾å¤‡çš„å¼€å‘ï¼ŒHTSæŠ€æœ¯çš„èŒƒå›´å·²ç»å¤§å¤§æ‰©å¤§ã€‚ä¸ä¼ ç»Ÿçš„ç­›æŸ¥æ–¹æ³•ç›¸æ¯”ï¼ŒHTSæŠ€æœ¯å…·æœ‰æ˜¾è‘—çš„ä¼˜åŠ¿ï¼ŒåŒ…æ‹¬ï¼š

(I)æ›´é«˜æ•ˆçš„è‡ªåŠ¨åŒ–æ“ä½œ-å…ˆè¿›çš„è®¾å¤‡æ”¹å–„äº†HTSçš„è‡ªåŠ¨åŒ–ï¼Œé˜²æ­¢äº†æ½œåœ¨çš„æ±¡æŸ“å’Œäººä¸ºé”™è¯¯ï¼›

(Ii)éœ€è¦æ›´å°‘çš„äººåŠ›èµ„æº-å»ºç«‹è‡ªåŠ¨åŒ–æ“ä½œç³»ç»Ÿä»¥åŠä½¿ç”¨å¾®å­”æ¿å’Œæµå¼ç»†èƒä»ªçš„åŸ¹å…»å’Œåˆ†ææ¨¡å¼æ˜¾è‘—é™ä½äº†åŠ³åŠ¨åŠ›æˆæœ¬ï¼›

(Iii)æ›´çµæ•å’Œå‡†ç¡®-æ–°çš„åˆ†ææ–¹æ³•é€šè¿‡æ£€æµ‹ä¸ç›®æ ‡ä»£è°¢ç‰©å«é‡ç›¸å…³çš„å˜åŒ–ï¼Œå®ç°äº†å¿«é€Ÿå’Œå‡†ç¡®çš„ç­›æŸ¥ï¼›

(Iv)æ ·å“ä½“ç§¯æ›´å°--å¯é çš„å®šé‡åªéœ€è¦å‡ å¾®å‡(å¾®æ¿)ç”šè‡³çº³ç±³å‡(æ¶²æ»´)ï¼Œå¤§å¤§é™ä½äº†åŸ¹å…»åŸºå’Œè¯•å‰‚çš„æˆæœ¬ã€‚

#### [3 Diverse Screening Library: Mutagenesis and Evolutionï¼ˆå¤šæ ·åŒ–ç­›é€‰æ–‡åº“ï¼šè¯±å˜ä¸è¿›åŒ–ï¼‰](#High-throughput screening(HTS))

##### [3.1Enrichment and Acclimationï¼ˆä»è‡ªç„¶æ–‡åº“ä¸­å¯Œé›†ä¸é©¯åŒ–ï¼‰](#High-throughput screening(HTS))

è‡ªç„¶ç•Œä¸­å­˜åœ¨å¤šç§å¾®ç”Ÿç‰©ï¼ŒåŒ…æ‹¬å¤ç”ŸèŒã€ç»†èŒã€é…µæ¯èŒã€æ”¾çº¿èŒå’ŒçœŸèŒã€‚è¿™äº›å¾®ç”Ÿç‰©é€šå¸¸ä¼šç§¯ç´¯æœ‰ç”¨çš„äº§å“ã€‚é€šè¿‡é•¿æœŸé€‚åº”ç¯å¢ƒå› ç´ ï¼ŒåŒ…æ‹¬pHã€æ¸©åº¦ã€æ¸—é€å‹ã€è¾å°„å’Œè¯±å˜ç‰©è´¨ï¼Œå¯ä»¥å¢å¼ºè¿™ä¸€èƒ½åŠ›ã€‚å› æ­¤ï¼Œç§¯ç´¯ç‰¹å®šå‘é…µäº§ç‰©çš„å¾®ç”Ÿç‰©èŒæ ªé¦–å…ˆä»è‡ªç„¶æ–‡åº“ä¸­å¯Œé›†å’Œé©¯åŒ–ï¼ˆ==å£è¿°å³å¯==ï¼‰

The general procedure for screening for a specific strain in a ==natural library== contains the following steps: 

(i) collecting samples rich in the target strain ï¼ˆæ”¶é›†å¯Œå«ç›®æ ‡èŒæ ªçš„æ ·æœ¬ï¼‰

(ii) enriching the target strain with a specific mediumï¼ˆç”¨ç‰¹å®šåŸ¹å…»åŸºå¯Œé›†ç›®æ ‡èŒæ ªï¼‰

(iii) separating pure species ï¼ˆåˆ†ç¦»çº¯ç§ï¼‰

(iv) determining the performance of the separate strainsï¼ˆç¡®å®šåˆ†ç¦»èŒæ ªçš„æ€§èƒ½ï¼‰

(v) identifying the most promising strain through sequencing analysisï¼ˆé€šè¿‡æµ‹åºåˆ†æç¡®å®šæœ€æœ‰å¸Œæœ›çš„èŒæ ªï¼‰

##### [3.2 Mutagenesis Technologiesï¼ˆè¯±å˜æŠ€æœ¯ï¼‰](#High-throughput screening(HTS))

1. ###### physical mutagenesis approaches ï¼š(Figure 2A)

   - UV light

   - Î±-rays

   - Î²-rays

   - Î³-rays

   - X-rays

2. ###### chemical mutagenesis approaches:    (Figure 2A)

   - alkylating agents ï¼ˆçƒ·åŸºåŒ–è¯•å‰‚ï¼‰

   - base analogs (ç¢±åŸºçš„ç±»ä¼¼ç‰©)

   - antibiotics ï¼ˆæŠ—ç”Ÿç´ ï¼‰

   - novel mutation methods

3. ###### novel mutation methods

   - atmospheric and room temperature plasma (ARTP)[17â€“19]ï¼ˆå¤§æ°”å’Œå®¤æ¸©ç­‰ç¦»å­ä½“ï¼‰

   - heavy ion irradiation[20,21]ï¼ˆé‡ç¦»å­è¾å°„ï¼‰

     ==@å°ç»„æˆå‘˜ï¼Œè¿™ä¸¤ä¸ªå¯ä»¥ç¨å¾®ä»‹ç»ä¸‹ï¼Œå‰é¢å°±ç¨å¾®è®²ä¸€è®²ç®€å•åŸç†å³å¯ï¼Œåç»­æˆ‘ä¼šç»§ç»­æ¶¦è‰²ä¸‹==

     è¿™ä¸¤ç§æ–¹æ³•çš„çªå˜ç‡æ›´é«˜ï¼Œçªå˜ä½ç‚¹æ›´éšæœºï¼Œä¸éœ€è¦æœ‰æ¯’æœ‰å®³çš„åŒ–å­¦ç‰©è´¨

4. ###### Adaptive Laboratory Evolution (ALE) ï¼ˆé€‚åº”æ€§çš„å®éªŒå®¤è¿›åŒ–ï¼‰(Figure 2B)

â€‹			Typical applications of this method include ï¼š

â€‹					(i) adapting microorganisms to tolerate harsh environ-mental stresses such as high osmotic pressure, low/high pH, or high/low temperature;

â€‹						(ä½¿å¾®ç”Ÿç‰©é€‚åº”ä¸¥é…·çš„ç¯å¢ƒå‹åŠ›ï¼Œå¦‚é«˜æ¸—é€å‹ã€ä½/é«˜pHæˆ–é«˜/ä½æ¸©)
â€‹					(ii) improving the capacity of strains with respect to growth rate, substrate consumption, or product accumulation

â€‹					(iii) activating potential pathways to synthesize nonnative products or consume nonnative substrates 

â€‹							ï¼ˆæ¿€æ´»åˆæˆéè‡ªèº«åˆæˆäº§å“é€šè·¯æˆ–æ¶ˆè€—éè‡ªèº«åº•ç‰©çš„æ½œåœ¨é€”å¾„ï¼‰



â€‹		==eVOLVER== and ==the microdroplet microbial culture (MMC) system== have been designed for microbial high-throughput 			cultivation and adaptive evolution.

eVOLVERã€4ã€‘å’Œå¾®æ»´å¾®ç”Ÿç‰©åŸ¹å…»(MMC)ã€5ã€‘ç³»ç»Ÿè¢«è®¾è®¡ç”¨äºå¾®ç”Ÿç‰©çš„é«˜é€šé‡åŸ¹å…»å’Œé€‚åº”æ€§è¿›åŒ–

@å°ç»„æˆå‘˜ï¼Œè¿™é‡Œé‡ç‚¹æ¥äº†é‡ç‚¹ä»‹ç»ä¸‹ï¼š

==Evolver==æ˜¯ä¸€ç§ç“¶å†…è¿ç»­åŸ¹å…»ç³»ç»Ÿï¼Œå¯ä»¥è¡¨å¾é…µæ¯å’Œç»†èŒçš„é€‚åº”æ€§ç”Ÿæ€ä½ã€‚å®ƒå¯ä»¥æœ‰æ•ˆåœ°å¹³è¡¡ååé‡ã€é‡å¤æ€§å’Œè´¨é‡ã€‚æ„å»ºäº†ä¸€ä¸ªé…å¤‡å¤šä¸ªä¼ æ„Ÿå™¨çš„å¾®å‹æ­¢è¡€å™¨ç³»ç»Ÿæ¥è¡¨å¾ä¸åŒæ¡ä»¶ä¸‹çš„é…µæ¯ç”Ÿç†

==MMC==åŸºäºå°†å¾®æ»´äº§ç”ŸèŠ¯ç‰‡ä¸æ£€æµ‹æ¨¡å—ç›¸ç»“åˆã€‚è¿™äº›ç³»ç»Ÿèƒ½å¤Ÿä»¥è¾ƒä½çš„æˆæœ¬å®ç°é«˜é€šé‡ç­›é€‰ã€‚

â€‹																												**Evolver**

![](C:\Users\å‡¤ç¾½ç©º\Desktop\ç»†èƒç”Ÿç‰©å­¦å°ç»„ä½œä¸š\å›¾ç‰‡åº“\eVOLVERæµç¨‹å›¾.webp)

5. ###### Directed Evolutionï¼ˆå®šå‘è¿›åŒ–)

Directed evolution is a powerful method for engineering enzymes and has been widely employed in industrial biosynthesis processes. it can be divided into nonrational design, rational design, and semirational design according to the methods used for building mutant librariesã€‚

å®šå‘è¿›åŒ–æ˜¯ä¸€ç§å¼ºæœ‰åŠ›çš„é…¶å·¥ç¨‹æ–¹æ³•ï¼Œåœ¨å·¥ä¸šç”Ÿç‰©åˆæˆè¿‡ç¨‹ä¸­å¾—åˆ°äº†å¹¿æ³›çš„åº”ç”¨ã€‚æ ¹æ®æ„å»ºçªå˜ä½“æ–‡åº“çš„æ–¹æ³•ä¸åŒï¼Œå¯åˆ†ä¸º==éç†æ€§è®¾è®¡==ã€==ç†æ€§è®¾è®¡==å’Œ==åŠç†æ€§è®¾è®¡==ã€‚(Figure 2C)

- Nonrational design is a random evolution strategy that does not require in-depth understanding of
   enzyme sequence and structure, and the main models include error-prone PCR, DNA shuffling,
   and saturation mutagenesis.(éç†æ€§è®¾è®¡æ˜¯ä¸€ç§ä¸éœ€è¦æ·±å…¥äº†è§£é…¶åºåˆ—å’Œç»“æ„çš„éšæœºè¿›åŒ–ç­–ç•¥ï¼Œå…¶ä¸»è¦æ¨¡å‹åŒ…æ‹¬å®¹æ˜“å‡ºé”™çš„pcrã€dnaæ”¹ç»„å’Œé¥±å’Œçªå˜ã€‚ï¼‰
- Rational design is based on smart computation strategies to simulate the kinetics and evolution of natural enzymes, through which target mutants can be screened in a more efficient wayï¼ˆåˆç†çš„è®¾è®¡æ˜¯åŸºäºæ™ºèƒ½çš„è®¡ç®—ç­–ç•¥æ¥æ¨¡æ‹Ÿå¤©ç„¶é…¶çš„åŠ¨åŠ›å­¦å’Œè¿›åŒ–ï¼Œé€šè¿‡å®ƒå¯ä»¥æ›´æœ‰æ•ˆåœ°ç­›é€‰ç›®æ ‡çªå˜ä½“ã€‚ï¼‰
- Semirational design is established by combining nonrational and rational designs. A series of semirational strategies have been devised, and semirational design is currently the most widely applied route because it takes advantage of sequence space and screening scale ï¼ˆåŠç†æ€§è®¾è®¡æ˜¯é€šè¿‡å°†éç†æ€§è®¾è®¡å’Œç†æ€§è®¾è®¡ç›¸ç»“åˆè€Œå»ºç«‹çš„ã€‚äººä»¬å·²ç»è®¾è®¡å‡ºäº†ä¸€ç³»åˆ—çš„åŠå¾ªç¯ç­–ç•¥ï¼Œå…¶ä¸­åŠå¾ªç¯è®¾è®¡ç”±äºåˆ©ç”¨äº†åºåˆ—ç©ºé—´å’Œç­›é€‰å°ºåº¦ï¼Œæ˜¯ç›®å‰åº”ç”¨æœ€å¹¿æ³›çš„ä¸€ç§ç­–ç•¥ï¼‰

6. ######  Random Assembly-Based Strategies ğŸ¤·â€â™€ï¸è¿™ä¸€æ®µæ¯”è¾ƒéš¾ ï¼ˆåŸºäºéšæœºè£…é…çš„ç­–ç•¥ï¼‰

To construct strain libraries in a more rational manner, many random assembly-based strategies
have been established, such as the random assembly of promoterâ€“5â€²-UTR (5â€²-untranslated
region) complexes with genes , multiplex automated genome engineering (MAGE) **ePathBrick**,**CasEMBLR**, and **COMPASS** (Figure 2D)

ä¸ºäº†ä»¥æ›´åˆç†çš„æ–¹å¼æ„å»ºèŒæ ªæ–‡åº“ï¼Œå·²ç»å»ºç«‹äº†è®¸å¤šåŸºäºéšæœºç»„è£…çš„ç­–ç•¥ï¼Œä¾‹å¦‚å¯åŠ¨å­-5â€˜-UTR(5â€™-éç¿»è¯‘åŒº)å¤åˆç‰©ä¸åŸºå› çš„éšæœºç»„è£…ã€å¤šé‡è‡ªåŠ¨åŒ–åŸºå› ç»„å·¥ç¨‹(**MAGE)**ã€**ePathBrick**ã€**CasEMBLR**å’Œ**COMPASS**ã€‚(Figure 2D)

ç”¨å¯åŠ¨å­-5â€˜-UTRå¤åˆä½“éšæœºç»„è£…åŸºå› æ˜¯ä¼˜åŒ–ç›®æ ‡äº§ç‰©ç”Ÿç‰©åˆæˆé€”å¾„çš„æœ€ç›´æ¥çš„ç­–ç•¥ã€‚MAGEï¼Œå®ƒæœ€åˆæ˜¯ç”±INEå¼€å‘çš„ã€‚Coliï¼Œcå’Œné€šè¿‡å¿«é€Ÿå’Œè¿ç»­åœ°ä¿®é¥°æŸ“è‰²ä½“ä¸Šçš„å¤šä¸ªä½ç‚¹æ¥å®ç°å¤§è§„æ¨¡çš„ç¼–ç¨‹å’Œè¿›åŒ–ã€‚å®ƒçš„å‡çº§ç‰ˆCRMAGEæ˜¯åœ¨CRISPR/CAS9å’ŒÎ»Redä»‹å¯¼çš„é‡ç»„å·¥ç¨‹çš„åŸºç¡€ä¸Šå¼€å‘çš„ã€‚æ­¤å¤–ï¼Œè¿˜ä¸ºçœŸæ ¸ç”Ÿç‰©(å¦‚é…¿é…’é…µæ¯)å»ºç«‹äº†**Emage**ã€‚**EPathBrick**æ–¹æ³•åŸºäºå››å¯¹ç­‰å°¾é“¾ä¸­çš„è½½ä½“ï¼Œä¸ºå¿«é€Ÿè®¾è®¡å’Œä¼˜åŒ–ä»£è°¢é€”å¾„æä¾›äº†ä¸€ä¸ªé€šç”¨çš„å¹³å°ã€‚**CasEMBLR**æ˜¯ä¸€ç§æ— æ ‡è®°çš„æ´»ä½“å¤šåŸºå› ç»„è£…æ–¹æ³•ï¼Œå®ƒå¯ä»¥å°†å«æœ‰åŒæºåºåˆ—çš„DNAç‰‡æ®µæ•´åˆåˆ°åŸºå› ç»„çš„ç‰¹å®šä½ç‚¹ä¸Šã€‚é…¿é…’å‚ã€‚é…å¤‡äº†å¤šä½ç‚¹**CRISPR/CAS9**ä»‹å¯¼çš„ä¿®é¥°çš„COMPASSå·²è¢«ç”¨äºç”Ÿäº§Î²-èƒ¡èåœç´ ä»¥åŠè”åˆç”Ÿäº§Î²-ç´«ç½—å…°é…®å’Œç”Ÿç‰©ä¼ æ„Ÿå™¨å“åº”å‹æŸšçš®è‹·å…ƒã€‚è¿™äº›éšæœºç»„è£…ç­–ç•¥å¯ç”¨äºæ„å»ºå…·æœ‰å¤§é‡ä¸åŒåŠŸèƒ½å’Œè°ƒèŠ‚å•å…ƒçš„å¤§è§„æ¨¡æ–‡åº“ï¼Œè¿™äº›åº“å¯èƒ½ä»¥çµæ´»çš„æ–¹å¼ç›¸äº’ä½œç”¨ã€‚

â€‹																	**Figure 2 Methods for mutagenesis**

![](C:\Users\å‡¤ç¾½ç©º\Desktop\ç»†èƒç”Ÿç‰©å­¦å°ç»„ä½œä¸š\å›¾ç‰‡åº“\Mutagenesis Technologies.jpg)

#### [4. Expanding the Search Range: Enabling Technologiesï¼ˆç°æœ‰çš„æŠ€æœ¯å¯ä»¥ç”¨æ¥æ‰©å¤§ç­›é€‰èŒƒå›´ï¼‰](#High-throughput screening(HTS))

##### [4.1 Spectroscopy Equipmentï¼ˆå…‰è°±åˆ†æï¼‰](#High-throughput screening(HTS))

**Mi-croplate readers** are the most commonly used equipment in HTS. Upgraded versions include a
**multilabel plate reader**â€”â€”a single desktop device with multiple detection modes

å¾®æ¿æ£€æµ‹å™¨æ˜¯HTSä¸­æœ€å¸¸ç”¨çš„è®¾å¤‡ã€‚å‡çº§ç‰ˆåŒ…æ‹¬å¤šæ ‡ç­¾æ¿æ£€æµ‹å™¨ï¼ˆå…·æœ‰å¤šç§æ£€æµ‹æ¨¡å¼çš„åŸºäºæ¡Œé¢ç«¯çš„è®¾å¤‡ï¼‰

A detection wavelength in the range 200â€“1000 nm can be used on a multilabel plate reader to detect absorbance,fluorescence intensity, time-resolved fluorescence,fluorescence polarization, and chemiluminescence . This approach been widely applied for detecting cell apoptosis or growth, metabolite content, enzyme activity, etc.

åœ¨200-1000  nmèŒƒå›´å†…çš„æ£€æµ‹æ³¢é•¿å¯ä»¥åœ¨å¤šæ ‡ç­¾æ¿é˜…è¯»å™¨ä¸Šä½¿ç”¨ï¼Œä»¥æ£€æµ‹å¸å…‰åº¦ã€è§å…‰å¼ºåº¦ã€æ—¶é—´åˆ†è¾¨è§å…‰ã€è§å…‰åæŒ¯å’ŒåŒ–å­¦å‘å…‰ã€‚è¯¥æ–¹æ³•è¢«å¹¿æ³›åº”ç”¨äº**ç»†èƒå‡‹äº¡æˆ–ç”Ÿé•¿ã€ä»£è°¢ç‰©å«é‡ã€é…¶æ´»æ€§ç­‰æ£€æµ‹**ã€‚

==ä»¥ä¸‹æ˜¯é‡ç‚¹==

In addition, researchers have also developed devices that can detect an extended range of chemicals based on Ramanã€‚ Fourier transform IR , and near-IR  spectra. Some of these devices have been further developed for high-throughput single-cell detection, analysis, and sorting by **exploiting fluorescence-activated cell sorting (FACS)**,**microfluidics**, and **optical tweezers**

å‚…ç«‹å¶å˜æ¢IRå’Œè¿‘IRå…‰è°±ã€‚é€šè¿‡åˆ©ç”¨**æµå¼ç»†èƒè§å…‰åˆ†é€‰(FACS)**ã€**å¾®æµæ§æŠ€æœ¯**å’Œ**å…‰å­¦é•Šå­**ï¼Œè¿™äº›è®¾å¤‡ä¸­çš„ä¸€äº›å·²ç»è¢«è¿›ä¸€æ­¥å¼€å‘ç”¨äºé«˜é€šé‡å•ç»†èƒæ£€æµ‹ã€åˆ†æå’Œåˆ†é€‰

##### [4.2 Automated Systems](#High-throughput screening(HTS))

 HTS mainly includes a **colony pickerï¼ˆèŒè½æ‹¾å–å™¨ï¼‰**, a **liquid-handling systemï¼ˆæ¶²ä½“å¤„ç†ç³»ç»Ÿï¼‰**, and **a multifunctional microplate readerï¼ˆå¤šåŠŸèƒ½å¾®æ¿è¯»å–å™¨ï¼‰** which **can be connected and operated under the control of a software system.ï¼ˆå¯åœ¨è½¯ä»¶ç«¯è¢«æ§åˆ¶ï¼‰** In addition, a series of accessory devices have been modified or redesigned for integration into a HTS system, including PCR machines, centrifuges, refrigerators,and sterilization and packaging systems.

HTSä¸»è¦åŒ…æ‹¬èŒè½æ‹¾å–å™¨ã€æ¶²ä½“å¤„ç†ç³»ç»Ÿå’Œå¯åœ¨è½¯ä»¶ç³»ç»Ÿçš„æ§åˆ¶ä¸‹è¿æ¥å’Œæ“ä½œçš„å¤šåŠŸèƒ½å¾®æ¿è¯»å–å™¨ã€‚æ­¤å¤–ï¼Œè¿˜å¯¹ä¸€ç³»åˆ—é™„ä»¶è®¾å¤‡è¿›è¡Œäº†æ”¹è£…æˆ–é‡æ–°è®¾è®¡ï¼Œä»¥é›†æˆåˆ°HTSç³»ç»Ÿä¸­ï¼ŒåŒ…æ‹¬PCRæœºå™¨ã€ç¦»å¿ƒæœºã€å†°ç®±ä»¥åŠç­èŒå’ŒåŒ…è£…ç³»ç»Ÿã€‚

â€‹							



â€‹									**Figure 3 Pipelines with Different Screening Throughputs.**

![](C:\Users\å‡¤ç¾½ç©º\Desktop\ç»†èƒç”Ÿç‰©å­¦å°ç»„ä½œä¸š\å›¾ç‰‡åº“\compostion of  HTS.jpg)

==å›¾ç‰‡è¯´æ˜==ï¼š

ä¸ä¼ ç»Ÿçš„ç­›é€‰æ–¹æ³•ç›¸æ¯”ï¼ŒåŸºäºèŒè½ç­›é€‰ã€æµå¼ç»†èƒè§å…‰åˆ†é€‰(FACS)å’Œæ¶²æ»´å¾®æµæ§æŠ€æœ¯çš„é«˜é€šé‡ç­›é€‰(HTS)çš„è§„æ¨¡å’Œæ•ˆç‡å·²é€æ­¥æé«˜ã€‚

- (A)ä»¥å¹³æ¿æ³•ä¸ºåŸºç¡€çš„ä¼ ç»Ÿç­›åˆ†ç®¡é“ï¼Œç­›åˆ†è§„æ¨¡ä¸º$10^3-10^4$

- (B)HTSæŠ€æœ¯ç®¡é“ï¼Œä»¥èŒè½é‡‡é›†å™¨ä¸ºåŸºç¡€ï¼Œç­›æŸ¥èŒƒå›´ä¸º$10^4-10^5$ã€‚

- (C)åŸºäºFACSçš„HTSç®¡é“(UHTS)ï¼Œç­›æŸ¥è§„æ¨¡ä¸º$10^8-10^9$ã€‚

- (D)åŸºäºå¾®æµæ§æŠ€æœ¯å’Œæµå¼ç»†èƒä»ªçš„HTSåˆæˆæµæ°´çº¿ï¼Œç­›é€‰è§„æ¨¡ä¸º$10^8-10^9$ï¼Œæé«˜äº†æ•ˆç‡ã€‚






##### [4.3 FACS](#High-throughput screening(HTS))ï¼ˆæµå¼ç»†èƒè§å…‰åˆ†é€‰æŠ€æœ¯ï¼‰/ï¼ˆFluorescence activated Cell Sortingï¼‰

ä»‹ç»FACSä¹‹å‰è®©æˆ‘ä»¬å…ˆçœ‹çœ‹ä»€ä¹ˆæ˜¯**FCï¼ˆæµå¼ç»†èƒæœ¯ï¼‰**

**Flow cytometry (FC)** can quickly analyze multiple parameters of a single cell and rapidly classify
target groups in multiple ways. Information from cells can be accurately detected using FC,
including cell density and size, internal complexity, and other fluorescence signals. FC is a prom-
ising technique for HTS owing to its ability to perform simultaneous quantitative and qualitative
analyses 

**æµå¼ç»†èƒæœ¯(FC) **å¯ä»¥å¿«é€Ÿåˆ†æå•ä¸ªç»†èƒçš„å¤šä¸ªå‚æ•°ï¼Œå¹¶ä»¥å¤šç§æ–¹å¼å¿«é€Ÿå¯¹ç›®æ ‡ç¾¤ä½“è¿›è¡Œåˆ†ç±»ã€‚ä½¿ç”¨FCå¯ä»¥å‡†ç¡®åœ°æ£€æµ‹æ¥è‡ªç»†èƒçš„ä¿¡æ¯ï¼ŒåŒ…æ‹¬**ç»†èƒå¯†åº¦å’Œå¤§å°**ã€**å†…éƒ¨å¤æ‚æ€§å’Œå…¶ä»–è§å…‰ä¿¡å·**ã€‚FCæ˜¯ä¸€ç§å¾ˆæœ‰å‰é€”çš„é«˜é€šé‡ç­›é€‰æŠ€æœ¯ï¼Œå› ä¸ºå®ƒèƒ½å¤Ÿ**åŒæ—¶è¿›è¡Œå®šé‡å’Œå®šæ€§åˆ†æ**

 FACS equipped with FC was developed to screen target cells at the single-cell level with high purity and throughput

é…å¤‡FCçš„æµå¼ç»†èƒä»ª(FACS)ï¼Œæ˜¯ç”¨äº**åœ¨å•ç»†èƒæ°´å¹³ç­›é€‰é«˜çº¯åº¦å’Œé«˜äº§é‡çš„é¶ç»†èƒ**

 FACS is well known for its ultra-high sorting speed, reaching up to 106cells/s. However, the main disadvantage of FACS is its high nonspecific background, and FACS-screened strains need to be further rescreened by a microplate-based HTS process.

FACSä»¥å…¶è¶…é«˜çš„åˆ†é€‰é€Ÿåº¦è€Œé—»åï¼Œæœ€é«˜å¯è¾¾$10^6$ä¸ªç»†èƒ/ç§’ã€‚ç„¶è€Œï¼ŒFACSçš„**ä¸»è¦ç¼ºç‚¹**æ˜¯å…¶**éç‰¹å¼‚æ€§èƒŒæ™¯è¾ƒé«˜ï¼ŒFACSç­›é€‰çš„èŒæ ªéœ€è¦é€šè¿‡==å¾®å­”æ¿HTSæŠ€æœ¯==è¿›è¡Œè¿›ä¸€æ­¥çš„å†ç­›é€‰**ã€‚

Most target products in industrial biotechnology are extracellular products that avoid intracellular
feedback inhibition and can also withstand downstream processing. FACS can only be used for
the analysis of intracellular or membrane-bound products that generate fluorescence signals that
correlate with the target compounds , and the use of FACS for analyzing extracellular products is challenging. Microfluidic FACS, which combines microfluidics and cell sorting, can overcome the limitations of traditional FACS, and has attracted considerable interest owing to its cost effective identification and separation methods

å·¥ä¸šç”Ÿç‰©æŠ€æœ¯çš„ç›®æ ‡äº§ç‰©å¤§å¤šæ˜¯èƒå¤–äº§ç‰©ï¼Œæ—¢èƒ½é¿å…ç»†èƒå†…åé¦ˆæŠ‘åˆ¶ï¼Œåˆèƒ½æŠµæŠ—ä¸‹æ¸¸åŠ å·¥ã€‚æµå¼ç»†èƒä»ªåªèƒ½ç”¨äºåˆ†æäº§ç”Ÿä¸ç›®æ ‡åŒ–åˆç‰©ç›¸å…³çš„è§å…‰ä¿¡å·çš„ç»†èƒå†…æˆ–è†œç»“åˆäº§ç‰©ï¼Œè€Œä½¿ç”¨æµå¼ç»†èƒä»ªåˆ†æèƒå¤–äº§ç‰©å…·æœ‰æŒ‘æˆ˜æ€§ã€‚**å¾®æµæ§FACSç»“åˆäº†å¾®æµæ§æŠ€æœ¯å’Œç»†èƒåˆ†é€‰æŠ€æœ¯ï¼Œå…‹æœäº†ä¼ ç»ŸFACSçš„å±€é™æ€§ï¼Œä»¥å…¶ç»æµé«˜æ•ˆçš„é‰´å®šå’Œåˆ†ç¦»æ–¹æ³•å¼•èµ·äº†äººä»¬çš„æå¤§å…´è¶£ã€‚**

æ³¨ï¼šè¿™é‡Œé¢åˆå¤šäº†ä¸€ä¸ªæ–°è¯==å¾®æµæ§FACS==

ä¸‹é¢å°±éš†é‡ä»‹ç»ä¸‹è¿™ä¸ªæ‰€è°“çš„**å¾®æµæ§æµå¼ç»†èƒè§å…‰åˆ†é€‰æŠ€æœ¯**   



##### [4.4 Microfluidics Technology](#High-throughput screening(HTS))(å¾®æµæ§æŠ€æœ¯)

Microfluidics is a technique for manipulatingfluids at the microliter to picoliter scale. It is an emerg-
ing interdisciplinary technology involving chemistry,fluid physics, microelectronics, materials, and
biology. Microfluidics technology generally employs a microfluidic chip, which is known as a 'lab
on a chip' owing to its ability to cover the most basic functions of biological and chemical labora-
tories. Based on microfluidic chip technology, a droplet-based microfluidic system has been de-
veloped for independent single-cell analysis. This has been used in several applications, such as
screening for overconsuming/secretory phenotypes and directed enzyme evolution, given its ad-
vantages that include high sensitivity, quantitative readout, and accuracy.

å¾®æµä½“æŠ€æœ¯æ˜¯ä¸€ç§åœ¨å¾®å‡åˆ°çš®å‡å°ºåº¦ä¸Šæ“çºµæµä½“çš„æŠ€æœ¯ã€‚å®ƒæ˜¯ä¸€é—¨æ–°å…´çš„äº¤å‰å­¦ç§‘ï¼Œæ¶‰åŠåŒ–å­¦ã€æµä½“ç‰©ç†ã€å¾®ç”µå­å­¦ã€ææ–™å’Œç”Ÿç‰©å­¦ã€‚å¾®æµæ§æŠ€æœ¯é€šå¸¸é‡‡ç”¨å¾®æµæ§èŠ¯ç‰‡ï¼Œç”±äºå…¶èƒ½å¤Ÿè¦†ç›–ç”Ÿç‰©å’ŒåŒ–å­¦å®éªŒå®¤çš„æœ€åŸºæœ¬åŠŸèƒ½ï¼Œå› æ­¤è¢«ç§°ä¸ºâ€œèŠ¯ç‰‡ä¸Šçš„å®éªŒå®¤â€ã€‚**åŸºäºå¾®æµæ§èŠ¯ç‰‡æŠ€æœ¯ï¼Œç ”åˆ¶äº†ä¸€ç§åŸºäºæ¶²æ»´çš„å•ç»†èƒç‹¬ç«‹åˆ†æå¾®æµæ§ç³»ç»Ÿ**ã€‚é‰´äºå®ƒçš„é«˜çµæ•åº¦ã€å®šé‡è¯»æ•°å’Œå‡†ç¡®æ€§ç­‰ä¼˜ç‚¹ï¼Œå®ƒå·²è¢«ç”¨äºå‡ ä¸ªåº”ç”¨ï¼Œå¦‚ç­›é€‰è¿‡åº¦æ¶ˆè€—/åˆ†æ³Œè¡¨å‹å’Œå®šå‘é…¶è¿›åŒ–ã€‚

Microfluidic chips can be designed that achieve packaging of single cells in a single droplet. Pro-
vision of substrates that generatefluorescence signals proportional to product concentration can
facilitate FACS analysis of the packaged droplets. The screening efficiency of droplet-based
microfluidic systems can be significantly enhanced by combining them with advanced methodsã€‚

å¾®æµæ§èŠ¯ç‰‡å¯ä»¥è®¾è®¡æˆåœ¨==**å•ä¸ªæ¶²æ»´ä¸­å®ç°å•ä¸ªç»†èƒçš„å°è£…**==ã€‚æä¾›èƒ½å¤Ÿäº§ç”Ÿä¸äº§å“æµ“åº¦æˆæ­£æ¯”çš„è§å…‰ä¿¡å·çš„åº•ç‰©å¯ä»¥ä¿ƒè¿›å¯¹åŒ…è£…æ¶²æ»´çš„æµå¼ç»†èƒä»ª(FACS)åˆ†æã€‚æ¶²æ»´å¾®æµæ§ç³»ç»Ÿä¸å…ˆè¿›çš„ç­›é€‰æ–¹æ³•ç›¸ç»“åˆï¼Œå¯ä»¥æ˜¾è‘—æé«˜å¾®æµæ§ç³»ç»Ÿçš„ç­›é€‰æ•ˆç‡ã€‚

 In addition, some detection techniques, such as mass spectrometry, Raman spectroscopy, and capillary approaches, can be integrated into a droplet-based microfluidic system for further expansion of the universality of the screening procedure [60,71,72]. Until recently the most obvious disadvantage of the microfluidic droplet method is that the encapsulating speed for obtaining uniform droplets is around$10^3-10^4$/s, which is **far below that of FACS**. Tailor-made microfluidic chips and high-performance droplet-stabilizing surfactants can alleviate this problem.

æ­¤å¤–ï¼Œä¸€äº›æ£€æµ‹æŠ€æœ¯ï¼Œå¦‚è´¨è°±ã€æ‹‰æ›¼å…‰è°±å’Œæ¯›ç»†ç®¡æ–¹æ³•ï¼Œå¯ä»¥é›†æˆåˆ°åŸºäºæ¶²æ»´çš„å¾®æµæ§ç³»ç»Ÿä¸­ï¼Œä»¥è¿›ä¸€æ­¥æ‰©å¤§ç­›æŸ¥ç¨‹åºçš„æ™®é€‚æ€§ã€‚åˆ°ç›®å‰ä¸ºæ­¢ï¼Œå¾®æµæ§æ¶²æ»´æ–¹æ³•æœ€æ˜æ˜¾çš„ç¼ºç‚¹æ˜¯è·å¾—å‡åŒ€æ¶²æ»´çš„åŒ…è¦†é€Ÿåº¦åœ¨$10^3-10^4$/s,å·¦å³ï¼Œè¿œè¿œä½äºFACSã€‚é‡èº«å®šåšçš„å¾®æµæ§èŠ¯ç‰‡å’Œé«˜æ•ˆç¨³å®šæ¶²æ»´çš„è¡¨é¢æ´»æ€§å‰‚å¯ä»¥ç¼“è§£è¿™ä¸€é—®é¢˜ã€‚



##### [4.5 High-Throughput Culture Systems](#High-throughput screening(HTS))(é«˜äº§çš„åŸ¹å…»æŠ€æœ¯)

Miniaturization is an important characteristic of HTS because it can reduce the amounts of biological and chemical samples that are required for analysis [63,73]. In general, high-throughput analysis is conducted in 96- or 384-well microtiter plates (MTPs), whereas high-throughput culture is mainly performed in deep 24-, 48-, and 96-well MTPs because of the need for culture medium and oxygen. High-throughput culture in MTPs would obviously increase the scope for screening target strains. To achieve a mixing effect in MTPs comparable with that of shakeflasks, shakers for MTP cultures should reach 800â€“1000 rpm, whereas a typicalflask shaker speed is ~100â€“300 rpm. In addition,**sandwich lids** are also useful for long-term MTP culture because both the rate of evaporation of fermentation broth and cross-contamination between wells can be significantly reduced

å°å‹åŒ–æ˜¯åˆ†ææ‰€éœ€ç”Ÿç‰©å’ŒåŒ–å­¦æ ·å“çš„ä¸€ä¸ªé‡è¦ç‰¹å¾ã€‚ä¸€èˆ¬æ¥è¯´ï¼Œé«˜é€šé‡åˆ†ææ˜¯åœ¨96å­”æˆ–384å­”çš„**å¾®æ»´å®šæ¿(MTP)**ä¸­è¿›è¡Œçš„ï¼Œè€Œé«˜é€šé‡åŸ¹å…»ä¸»è¦æ˜¯åœ¨**24å­”ã€48å­”å’Œ96å­”çš„æ·±å­”MTP**ä¸­è¿›è¡Œçš„ï¼Œå› ä¸ºéœ€è¦åŸ¹å…»åŸºå’Œæ°§æ°”ã€‚åœ¨MTPä¸­è¿›è¡Œé«˜é€šé‡åŸ¹å…»å°†æ˜æ˜¾å¢åŠ ç­›é€‰ç›®æ ‡èŒæ ªçš„èŒƒå›´ã€‚ä¸ºäº†åœ¨MTPä¸­è·å¾—ä¸æ‘‡ç“¶ç›¸å½“çš„æ··åˆæ•ˆæœï¼ŒMTPåŸ¹å…»çš„æ‘‡åºŠè½¬é€Ÿåº”è¾¾åˆ°800-1000rpmï¼Œè€Œæ‘‡ç“¶æ‘‡åºŠçš„å…¸å‹é€Ÿåº¦ä¸º100-300rpmã€‚æ­¤å¤–ï¼Œ**ä¸‰æ˜æ²»ç›–**å¯¹é•¿æœŸåŸ¹å…»MTPä¹Ÿå¾ˆæœ‰ç”¨ï¼Œå› ä¸ºå‘é…µæ¶²çš„è’¸å‘é€Ÿåº¦å’Œäº•é—´çš„äº¤å‰æ±¡æŸ“éƒ½å¯ä»¥æ˜¾è‘—é™ä½ã€‚

å¥‡æ€ªçš„è¯æ±‡åˆå¤šäº†ä¸€ä¸ª **sandwich lids**??

An ideal microculture device should generally be able to accurately reproduce large-scale cultivation conditions and reflect the physiological metabolism and production capacity of the microorganism . Traditional rescreening is usually performed in shake flasks and bioreactors in sequence. However, the 	process parameters in shake flasks are difficult to measure and regulate in real time, thus seriously limiting the amplification of an improved strain in a bioreactor .**Microbioreactors** have been designed for high-throughput optimization to replace traditional two-step fermentation in shake flasks and bioreactors by a one-step integrated process. The evolved design is further equipped with a waterless temperature-control system, microvalve-controlled feeding, and noninvasive optical pH and dissolved oxygen (DO) biosensors. However, these techniques need further improvement, especially regarding the detection range and sensitivity of pH and DO electrodes in the very limited culture volume 

ä¸€ä¸ªç†æƒ³çš„å¾®åŸ¹å…»è£…ç½®ä¸€èˆ¬åº”è¯¥èƒ½å¤Ÿå‡†ç¡®åœ°å¤åˆ¶å¤§è§„æ¨¡çš„åŸ¹å…»æ¡ä»¶ï¼Œå¹¶åæ˜ å¾®ç”Ÿç‰©çš„ç”Ÿç†ä»£è°¢å’Œç”Ÿäº§èƒ½åŠ›ã€‚ä¼ ç»Ÿçš„å¤ç­›é€šå¸¸æ˜¯åœ¨**æ‘‡ç“¶å’Œç”Ÿç‰©ååº”å™¨ä¸­æŒ‰é¡ºåºè¿›è¡Œ**çš„ã€‚ç„¶è€Œï¼Œ**æ‘‡ç“¶ä¸­çš„å·¥è‰ºå‚æ•°å¾ˆéš¾å®æ—¶æµ‹é‡å’Œè°ƒèŠ‚**ï¼Œå› æ­¤ä¸¥é‡é™åˆ¶äº†æ”¹è‰¯èŒæ ªåœ¨ç”Ÿç‰©ååº”å™¨ä¸­çš„æ”¾å¤§ã€‚å¾®ç”Ÿç‰©ååº”å™¨æ˜¯ä¸ºé«˜é€šé‡ä¼˜åŒ–è€Œè®¾è®¡çš„ï¼Œç”¨ä¸€**æ­¥é›†æˆå·¥è‰ºå–ä»£äº†æ‘‡ç“¶å’Œç”Ÿç‰©ååº”å™¨ä¸­ä¼ ç»Ÿçš„ä¸¤æ­¥å‘é…µ**ã€‚è¿™ä¸ªè¿›åŒ–è®¾è®¡è¿›ä¸€æ­¥**é…å¤‡äº†æ— æ°´æ¸©åº¦æ§åˆ¶ç³»ç»Ÿ**ã€**å¾®é˜€æ§åˆ¶è¿›æ–™ä»¥åŠéä¾µå…¥å¼å…‰å­¦pHå’Œæº¶è§£æ°§(DO)ç”Ÿç‰©ä¼ æ„Ÿå™¨**ã€‚ç„¶è€Œï¼Œè¿™äº›æŠ€æœ¯è¿˜éœ€è¦è¿›ä¸€æ­¥æ”¹è¿›ï¼Œç‰¹åˆ«æ˜¯åœ¨éå¸¸æœ‰é™çš„åŸ¹å…»é‡ä¸‹ï¼ŒpHå’ŒDOç”µæçš„æ£€æµ‹èŒƒå›´å’Œçµæ•åº¦æ–¹é¢ã€‚



#### [5. Highlighting Target Compounds: Detection Methods](#High-throughput screening(HTS))(çªå‡ºç›®æ ‡åŒ–åˆç‰©ï¼šæ£€æµ‹æ–¹æ³•)

##### [5.1 UV/Visible Spectroscopy-Based Screeningï¼ˆç´«å¤–æˆ–è€…åŸºäºå¯è§å…‰å…‰è°±çš„ç­›é€‰æ–¹æ³•ï¼‰](#High-throughput screening(HTS))

 These can be divided into direct and indirect detection methods (Figure 4A). Products with a relatively complex molecular structure or innate color properties, such as avermectin [10], cephalosporin C [74], lycopene , and p-coumaric acid , can be screened through direct measurement of absorbance. Some products that have no obvious absorbance characteristics for direct detection can be detected by inclusion of pH indicators, chelation with metal ions, or coupling with enzymatic or chemical reactions. For example, if a strain accumulates a single type of organic acid as the target product, a screening procedure
can be established by adding suitable pH indicators . A low pH not only indicates that the strain accumulates more organic acid, but also shows that the strain has the capacity to tolerate a lower pH. For more specific detection of a target organic acid, such as pyruvic acid, a screening process can be established by adding a chelation ion that generates a detectable yellow complex. In addition, screening methods have been developed based on chemical or coupled enzyme reactions which establish quantitative relationships between target metabolite concentration and chromogenic substances such as ATP/ADP [83] and NAD(P)+[84]. Some typical HTS methods and their applications in screening industrial microorganisms are listed inTable 1. A large number of selected strains with improved performance have been successfully applied in industrial-scale production.

è¿™äº›æ–¹æ³•å¯åˆ†ä¸º**ç›´æ¥æ£€æµ‹æ³•**å’Œ**é—´æ¥æ£€æµ‹æ³•**(å›¾4A)ã€‚**å…·æœ‰ç›¸å¯¹å¤æ‚çš„åˆ†å­ç»“æ„æˆ–å¤©ç„¶é¢œè‰²ç‰¹æ€§çš„äº§å“**ï¼Œå¦‚é˜¿ç»´èŒç´ ã€å¤´å­¢èŒç´ Cã€ç•ªèŒ„çº¢ç´ å’Œå¯¹é¦™è±†é…¸ï¼Œå¯ä»¥**é€šè¿‡ç›´æ¥æµ‹é‡å¸å…‰åº¦æ¥ç­›é€‰**ã€‚ä¸€äº›**æ²¡æœ‰æ˜æ˜¾å¸æ”¶ç‰¹æ€§å¯ç›´æ¥æ£€æµ‹çš„äº§å“**ï¼Œå¯**é€šè¿‡åŠ å…¥pHæŒ‡ç¤ºå‰‚ã€ä¸é‡‘å±ç¦»å­è¯åˆæˆ–ä¸é…¶ååº”æˆ–åŒ–å­¦ååº”è€¦åˆçš„æ–¹æ³•è¿›è¡Œæ£€æµ‹**ã€‚

~~ä¾‹å¦‚ï¼Œå¦‚æœèŒæ ªç§¯ç´¯äº†å•ä¸€ç±»å‹çš„æœ‰æœºé…¸ä½œä¸ºç›®æ ‡äº§ç‰©ï¼Œåˆ™å¯ä»¥é€šè¿‡æ·»åŠ åˆé€‚çš„pHæŒ‡ç¤ºå‰‚æ¥å»ºç«‹ç­›é€‰ç¨‹åºã€‚ä½pHä¸ä»…è¡¨æ˜è¯¥èŒæ ªç§¯ç´¯äº†è¾ƒå¤šçš„æœ‰æœºé…¸ï¼Œè€Œä¸”è¡¨æ˜è¯¥èŒæ ªå…·æœ‰è€ä½pHçš„èƒ½åŠ›ã€‚ä¸ºäº†æ›´å…·ä½“åœ°æ£€æµ‹ç›®æ ‡æœ‰æœºé…¸ï¼Œä¾‹å¦‚ä¸™é…®é…¸ï¼Œå¯ä»¥é€šè¿‡æ·»åŠ ç”Ÿæˆå¯æ£€æµ‹çš„é»„è‰²ç»œåˆç‰©çš„è¯åˆç¦»å­æ¥å»ºç«‹ç­›é€‰è¿‡ç¨‹ã€‚~~

æ­¤å¤–ï¼Œè¿˜å‘å±•äº†**åŸºäºåŒ–å­¦æˆ–å¶è”é…¶ååº”çš„ç­›é€‰æ–¹æ³•**ï¼Œè¿™äº›ååº”**å»ºç«‹äº†ç›®æ ‡ä»£è°¢ç‰©æµ“åº¦ä¸æ˜¾è‰²ç‰©è´¨(å¦‚ATP/ADPï¼‰å’ŒNAD(P)+)ä¹‹é—´çš„å®šé‡å…³ç³»**ã€‚è¡¨1åˆ—å‡ºäº†å‡ ç§å…¸å‹çš„HTSæ–¹æ³•åŠå…¶åœ¨å·¥ä¸šå¾®ç”Ÿç‰©ç­›é€‰ä¸­çš„åº”ç”¨ã€‚å¤§é‡ç­›é€‰å‡ºçš„æ€§èƒ½è¾ƒå¥½çš„èŒæ ªå·²æˆåŠŸåº”ç”¨äºå·¥ä¸šåŒ–ç”Ÿäº§ã€‚

##### [5.2 Fluorescence Spectroscopy-Based Screeningï¼ˆåŸºäºè§å…‰å…‰è°±æŠ€æœ¯çš„ç­›æŸ¥ï¼‰](#High-throughput screening(HTS))

Similarly to UV/visible spectroscopy-based HTS,fluorescence spectroscopy-based HTS can be
divided into direct and indirect detection methods according to the characteristics of the target
product (Figure 4B). For instance, riboflavin hasfluorescence excitation/emission wavelengths
at 450/518 nm, and Yarrowia lipolytica mutants with increased riboflavin production could be
screened based onfluorescence intensity at 518 nm [54]. The use offluorescent dyes/probes
for screening is a common approach, such as labeling dead or live cells with dyes [10], analyzing
lipids and single-cell oils with Nile red [85,86], and quantifying menaquinone and polymalic acid
with rhodamine [87,88]. Interestingly, before screening based on Nile red, the density of
Y. lipolyticawas used for prescreening of more efficient lipogenic strains through the identification
offloating cells [89]. Methods based on chemical or enzyme-coupled reactions that generate
fluorescent signals have also been widely used for the efficient selection of improved industrial microorganisms [38,48]. HTS based on fluorescence can achieve ultra-HTS (uHTS) because it per-
mits an increase in speed and a reduction in scale comparable with FACS. Fluorescence
spectroscopy may be further expanded to biosensor-based HTS.

ä¸åŸºäºç´«å¤–/å¯è§å…‰å…‰è°±çš„HTSæŠ€æœ¯ç±»ä¼¼ï¼ŒåŸºäºè§å…‰å…‰è°±çš„HTSæŠ€æœ¯å¯æ ¹æ®ç›®æ ‡äº§å“çš„ç‰¹æ€§åˆ†ä¸º**ç›´æ¥æ£€æµ‹æ–¹æ³•**å’Œ**é—´æ¥æ£€æµ‹æ–¹æ³•**(å›¾4B)ã€‚

~~ä¾‹å¦‚ï¼Œæ ¸é»„ç´ çš„è§å…‰æ¿€å‘/å‘å°„æ³¢é•¿åœ¨450/518  nmï¼Œæ ¹æ®518  nmçš„è§å…‰å¼ºåº¦å¯ä»¥ç­›é€‰å‡ºæ ¸é»„ç´ äº§é‡å¢åŠ çš„äºšç½—ç»´æ°è„‚è´¨ä½“çªå˜æ ªã€‚ä½¿ç”¨è§å…‰æŸ“æ–™/æ¢é’ˆè¿›è¡Œç­›é€‰æ˜¯ä¸€ç§å¸¸ç”¨çš„æ–¹æ³•ï¼Œä¾‹å¦‚ç”¨æŸ“æ–™æ ‡è®°æ­»äº¡æˆ–æ´»ç»†èƒï¼Œç”¨å°¼ç½—çº¢åˆ†æè„‚è´¨å’Œå•ç»†èƒæ²¹ï¼Œç”¨ç½—ä¸¹æ˜å®šé‡å­Ÿå–¹é…®å’Œå¤šèšé©¬æ¥é…¸ã€‚æœ‰è¶£çš„æ˜¯ï¼Œåœ¨åŸºäºå°¼ç½—çº¢çš„ç­›é€‰ä¹‹å‰ï¼Œè§£è„‚è€¶å°”æ£®æ°èŒçš„å¯†åº¦è¢«ç”¨æ¥é€šè¿‡é‰´å®šè„±è½ç»†èƒæ¥é¢„ç­›é€‰æ›´æœ‰æ•ˆçš„äº§è„‚èŒæ ªã€‚~~

**åŸºäºäº§ç”Ÿè§å…‰ä¿¡å·çš„åŒ–å­¦**æˆ–**é…¶å¶è”ååº”çš„æ–¹æ³•**ä¹Ÿè¢«å¹¿æ³›ç”¨äºé«˜æ•ˆé€‰æ‹©æ”¹è‰¯çš„å·¥ä¸šå¾®ç”Ÿç‰©ã€‚åŸºäºè§å…‰çš„HTSæŠ€æœ¯å¯ä»¥å®ç°è¶…HTSæŠ€æœ¯(UHTS)ï¼Œå› ä¸ºå®ƒå…è®¸é€Ÿåº¦çš„æé«˜å’Œè§„æ¨¡çš„ç¼©å°ï¼Œå¯ä»¥ä¸FACSç›¸åª²ç¾ã€‚è§å…‰å…‰è°±å­¦å¯ä»¥è¿›ä¸€æ­¥æ‰©å±•åˆ°åŸºäºç”Ÿç‰©ä¼ æ„Ÿå™¨çš„HTSæŠ€æœ¯ã€‚

##### [5.3 Biosensor-Based Fluorescence Spectroscopy Screening(åŸºäºç”Ÿç‰©ä¼ æ„Ÿå™¨çš„è§å…‰å…‰è°±ç­›é€‰)](#High-throughput screening(HTS))ã€‚ (Figure 4C)

 A biosensor consists of a sensor and a reporter. The sensor identifies specific intracellular metabolites, while the reporter generates quantitative signals through a series of programmed genetic circuits linked to the sensor signal. A series of biosensors have been developed for uHTS based on this principle. Biosensors are generally of two typesâ€“protein-based biosensors and nucleic acid-based biosensors. Most protein -based biosensors are based on transcription factors (TFs) and engineered fluorescent proteins (FPs), whereas nucleic acid-based biosensors mainly include RNA riboswitches, RNA Spinach, and structure switching-based DNA biosensors 

ç”Ÿç‰©ä¼ æ„Ÿå™¨ç”±**ä¼ æ„Ÿå™¨**å’Œ**ä¼ å¯¼å™¨**ç»„æˆã€‚**ä¼ æ„Ÿå™¨è¯†åˆ«ç‰¹å®šçš„ç»†èƒå†…ä»£è°¢ç‰©**ï¼Œè€Œ**ä¼ å¯¼å™¨**é€šè¿‡ä¸€ç³»åˆ—ä¸ä¼ æ„Ÿå™¨ä¿¡å·ç›¸è¿çš„ç¨‹åºåŒ–é—ä¼ ç”µè·¯**äº§ç”Ÿå®šé‡ä¿¡å·**ã€‚

åŸºäºè¿™ä¸€åŸç†ï¼Œå·²ç ”åˆ¶å‡ºä¸€ç³»åˆ—ç”¨äºHTSçš„ç”Ÿç‰©ä¼ æ„Ÿå™¨

ç”Ÿç‰©ä¼ æ„Ÿå™¨é€šå¸¸æœ‰ä¸¤ç§ç±»å‹-åŸºäºè›‹ç™½è´¨çš„ç”Ÿç‰©ä¼ æ„Ÿå™¨å’ŒåŸºäºæ ¸é…¸çš„ç”Ÿç‰©ä¼ æ„Ÿå™¨ã€‚

å¤§å¤šæ•°**åŸºäºè›‹ç™½è´¨çš„ç”Ÿç‰©ä¼ æ„Ÿå™¨æ˜¯åŸºäºè½¬å½•å› å­(TF)å’Œå·¥ç¨‹è§å…‰è›‹ç™½(FP)çš„**ï¼Œ

è€Œ**åŸºäºæ ¸é…¸çš„ç”Ÿç‰©ä¼ æ„Ÿå™¨**ä¸»è¦åŒ…æ‹¬ï¼š

- RNAæ ¸ç³–å¼€å…³
- RNA Spinach
- åŸºäºç»“æ„è½¬æ¢çš„DNAç”Ÿç‰©ä¼ æ„Ÿå™¨



##### [5.4 Electrochemical Sensor (ES)-Based Screening(åŸºäºç”µåŒ–å­¦ä¼ æ„Ÿå™¨(ES)çš„ç­›é€‰)](#High-throughput screening(HTS))

 In HTS, ES techniques have been employed to enhance the activity of enzymes associated with NAD(P)H or H2O2, mainly oxidoreductases and oxidases (Figure 4D); however, few studies have addressed ES applications for the detection of particular fermented products in industrial biotechnology.

åœ¨HTSæŠ€æœ¯ä¸­ï¼ŒESæŠ€æœ¯è¢«**ç”¨æ¥å¢å¼ºä¸NAD(P)Hæˆ–$H_2O_2$ç›¸å…³çš„é…¶çš„æ´»æ€§**ï¼Œä¸»è¦æ˜¯**æ°§åŒ–è¿˜åŸé…¶å’Œæ°§åŒ–é…¶**ï¼›ç„¶è€Œï¼Œå¾ˆå°‘æœ‰ç ”ç©¶æ¶‰åŠESåœ¨å·¥ä¸šç”Ÿç‰©æŠ€æœ¯ä¸­æ£€æµ‹ç‰¹å®šå‘é…µäº§ç‰©çš„åº”ç”¨ã€‚



##### [5.5 Screening Based on Advanced Spectroscopic Techniques(åŸºäºå…ˆè¿›å…‰è°±æŠ€æœ¯çš„ç­›é€‰)](#High-throughput screening(HTS))

To enhance the sorting efficiency and obtain industrial producers with specific target phenotypes,
spectroscopic techniques based on advanced instrument platforms such as Raman, Fourier transform IR (FTIR), and Fourier transform near-IR (FTNIR) spectroscopy are being applied in industrial biotechnology (Figure 4E). Raman spectroscopy is based on the Raman effect, and has advantages of rapid, sensitive, nondestructive, and real-time detection. A HTS Raman spectroscopy platform was recently established for label-free screening of single cells and biocatalysts . Similarly to Raman spectroscopy, FTIR and FTNIR spectroscopy are also non-destructive analytical methods with the advantages of high throughput and rapid and automated detection. These two analytical methods have been employed for screening *Aurantiochytrium*  sp. Mucorsp.,and S. cerevisiae. These spectroscopic techniques and their advanced imaging technologies integrated with confocal laser scanning microscopy have great potential in industrial HTS.

ä¸ºäº†æé«˜åˆ†é€‰æ•ˆç‡ï¼Œè·å¾—å…·æœ‰ç‰¹å®šç›®æ ‡è¡¨å‹çš„å·¥ä¸šç”Ÿäº§è€…ï¼ŒåŸºäºå…ˆè¿›çš„ä»ªå™¨å¹³å°(å¦‚æ‹‰æ›¼ã€å‚…ç«‹å¶ç­‰)çš„å…‰è°±æŠ€æœ¯

**å‚…ç«‹å¶å˜æ¢==çº¢å¤–å…‰è°±==(FTIR)**å’Œ**å‚…ç«‹å¶å˜æ¢==è¿‘==çº¢å¤–å…‰è°±(FTNIR)**æ­£åœ¨å·¥ä¸šç”Ÿç‰©æŠ€æœ¯ä¸­å¾—åˆ°åº”ç”¨(Figure 4E)ã€‚æ‹‰æ›¼å…‰è°±æ˜¯åŸºäºæ‹‰æ›¼æ•ˆåº”ï¼Œå…·æœ‰å¿«é€Ÿã€çµæ•ã€æ— æŸã€å®æ—¶æ£€æµ‹ç­‰ä¼˜ç‚¹ã€‚

æœ€è¿‘å»ºç«‹äº†**HTSæ‹‰æ›¼å…‰è°±å¹³å°**ï¼Œç”¨äºå•ç»†èƒå’Œç”Ÿç‰©å‚¬åŒ–å‰‚çš„æ— æ ‡è®°ç­›é€‰ã€‚

ä¸æ‹‰æ›¼å…‰è°±ç±»ä¼¼ï¼Œ**FTIRå’ŒFTNIRå…‰è°±**ä¹Ÿæ˜¯æ— æŸåˆ†ææ–¹æ³•ï¼Œå…·æœ‰é«˜é€šé‡ã€å¿«é€Ÿã€è‡ªåŠ¨åŒ–æ£€æµ‹ç­‰ä¼˜ç‚¹ã€‚è¿™ä¸¤ç§åˆ†ææ–¹æ³•å·²ç”¨äº**é‡‘é»„è‰²è‘¡è„çƒèŒ**(Aurantiochytrium  sp.)ã€**æ¯›éœ‰(**Mucorsp.)çš„ç­›é€‰å½“ä¸­ã€‚

è¿™äº›å…‰è°±æŠ€æœ¯åŠå…¶å…ˆè¿›çš„æˆåƒæŠ€æœ¯ä¸å…±èšç„¦æ¿€å…‰æ‰«ææ˜¾å¾®é•œç›¸ç»“åˆï¼Œåœ¨å·¥ä¸šHTSé¢†åŸŸå…·æœ‰å·¨å¤§çš„æ½œåŠ›ã€‚



==é‡ç‚¹å…³æ³¨è¿™å¼ å›¾== Figure 4 

@å°ç»„æˆå‘˜ï¼Œä¸‹é¢è¿™å¼ å›¾ä¸Šé¢çš„ä¸œè¥¿æ˜ç™½äº†å°±éƒ½æ˜ç™½äº†



â€‹				**Figure 4. General Strategies for Establishing High-Throughput Screening (HTS).**

![](C:\Users\å‡¤ç¾½ç©º\Desktop\ç»†èƒç”Ÿç‰©å­¦å°ç»„ä½œä¸š\å›¾ç‰‡åº“\1-s2.0-S0167779920300019-gr4_lrg.jpg)

 **Figure 4è¯´æ˜ï¼š**

Different strategies have been employed to highlight the target products for establishing HTS for screening high-performance microorganisms.

(A) Absorbance-based strategies include (1) direct detection based on the molecular structure or an
innate color property of the target product; (2) indirect detection by, for example, the addition of a pH indicator, metal ion chelation, and coupling with enzymatic or
chemical reactions. 

**(A)åŸºäºå¸å…‰åº¦çš„ç­–ç•¥åŒ…æ‹¬(1)åŸºäºç›®æ ‡äº§å“çš„åˆ†å­ç»“æ„æˆ–å›ºæœ‰é¢œè‰²å±æ€§çš„ç›´æ¥æ£€æµ‹ï¼›(2)é€šè¿‡ä¾‹å¦‚æ·»åŠ pHæŒ‡ç¤ºå‰‚ã€é‡‘å±ç¦»å­è¯åˆä»¥åŠä¸é…¶ååº”æˆ–åŒ–å­¦ååº”è€¦åˆçš„é—´æ¥æ£€æµ‹ã€‚**

(B) Fluorescence-based strategies include (1) direct detection based on innate fluorescence of the target product; (2) indirect detection using a dye/pH probe, metal ion, and coupling with enzymatic or chemical reaction. 

**(B)åŸºäºè§å…‰çš„ç­–ç•¥åŒ…æ‹¬ï¼š(1)åŸºäºç›®æ ‡äº§å“çš„å¤©ç„¶è§å…‰çš„ç›´æ¥æ£€æµ‹ï¼›(2)ä½¿ç”¨æŸ“æ–™/pHæ¢é’ˆã€é‡‘å±ç¦»å­ä»¥åŠä¸é…¶ååº”æˆ–åŒ–å­¦ååº”è€¦åˆçš„é—´æ¥æ£€æµ‹ã€‚**

(C) Electrochemical Sensor (ES)-based strategies. 

**(C)åŸºäºç”µåŒ–å­¦ä¼ æ„Ÿå™¨(ES)çš„ç­–ç•¥**

(D) Biosensor-based strategies including
(1) transcription factors (TFs); (2)fluorescent proteins (FPs) and detection by FÃ¶rster resonance energy transfer (FRET); (3) RNA riboswitch based on ribosome binding
sites (RBS); (4) RNA riboswitch based on ribozymes; (5) RNA Spinach; (6) DNA biosensors. 

**(D)åŸºäºç”Ÿç‰©ä¼ æ„Ÿå™¨çš„ç­–ç•¥ï¼ŒåŒ…æ‹¬(1)è½¬å½•å› å­(TF)ï¼›(2)è§å…‰è›‹ç™½(FPs)å’ŒFÃ¶rsterå…±æŒ¯èƒ½é‡è½¬ç§»(FRET)æ£€æµ‹ï¼›(3)åŸºäºæ ¸ç³–ä½“ç»“åˆä½ç‚¹(RBS)çš„RNAæ ¸ç³–å¼€å…³ï¼›(4)åŸºäºæ ¸é…¶çš„RNAæ ¸ç³–å¼€å…³ï¼›(5)RNA  Spinachï¼›(6)DNAç”Ÿç‰©ä¼ æ„Ÿå™¨ã€‚**

(E) Special spectrum-based strategies such as Raman (RS), Fourier transform IR (FTIR), and Fourier transform near-IR (FTNIR) spectroscopy.

**(E)åŸºäºå…‰è°±çš„ç‰¹æ®Šç­–ç•¥ï¼Œä¾‹å¦‚æ‹‰æ›¼(RS)ã€å‚…é‡Œå¶å˜æ¢çº¢å¤–(FTIR)å’Œå‚…ç«‹å¶å˜æ¢è¿‘çº¢å¤–(FTNIR)å…‰è°±ã€‚**





#### [6. Concluding Remarks and Future Perspectives(ç»“æŸè¯­å’Œæœªæ¥å±•æœ›)](#High-throughput screening(HTS))

å¯¹å‰æ–‡è¿›è¡Œç®€å•çš„æ€»ç»“ï¼š

MTP-based HTS techniques have improved both automation and throughput for obtaining indus-
trial microorganisms with better phenotypes, resulting in less labor-intensive and more efficient
workflows. FACS- and microfluidics-based HTS techniques, in combination with differentfluores-
cent probes and biosensors, have significantly improved screening efficiency from $10^5$/day to
/$10^{11}$day.

**åŸºäºMTPçš„HTSæŠ€æœ¯****æé«˜äº†è·å¾—è¡¨å‹æ›´å¥½çš„å·¥ä¸šå¾®ç”Ÿç‰©çš„**è‡ªåŠ¨åŒ–å’Œååé‡**ï¼Œä»è€Œå‡å°‘äº†åŠ³åŠ¨å¯†é›†å‹ï¼Œæé«˜äº†å·¥ä½œæµç¨‹çš„æ•ˆç‡ã€‚**åŸºäºFACSå’Œå¾®æµæ§æŠ€æœ¯çš„HTSæŠ€æœ¯**ä¸ä¸åŒçš„è§å…‰æ¢é’ˆå’Œç”Ÿç‰©ä¼ æ„Ÿå™¨ç›¸ç»“åˆï¼Œå¤§å¤§**æé«˜äº†ç­›æŸ¥æ•ˆç‡**ï¼Œä»$10^5$/å¤©æé«˜åˆ°$10^{11}$/å¤©ã€‚ 

==æ³¨æ„åŒºåˆ†äºŒè€…==

ç›®å‰ä¾æ—§å­˜åœ¨çš„ä¸è¶³ï¼š

However, an enzyme harboring 1000 amino acid residues could theoretically generate up to $19^{1000}$variants, and current screening throughput is far below this magnitude.

ç„¶è€Œï¼Œä¸€ç§å«æœ‰1000ä¸ªæ°¨åŸºé…¸æ®‹åŸºçš„é…¶ç†è®ºä¸Šå¯ä»¥äº§ç”Ÿé«˜è¾¾$19^{1000}$ä¸ªå˜å¼‚ä½“ï¼Œè€Œç›®å‰çš„ç­›é€‰ååé‡è¿œè¿œä½äºè¿™ä¸ªæ•°é‡çº§ã€‚

å±•æœ›æœªæ¥ï¼š

 the development of screening techniques that are more efficient than FACS-based methods, using nanotechnology and electronic techniques, is an important goal. Nanotechnology is an emerging technology in which the nanopores and nanoprobes have been used to analyze tumor cells and pathogenic bacteria. Combined with the microfluidics and other measurement techniques, these technologies have great potential for constructing more sensitive biosensor systems to screen a greater diversity metabolites or enzymes, and further enhance screening efficiency.

æ¯”åŸºäºFACSçš„æ–¹æ³•æ›´æœ‰æ•ˆçš„ç­›æŸ¥æŠ€æœ¯ï¼Œ**çº³ç±³æŠ€æœ¯**å’Œ**ç”µå­æŠ€æœ¯å¼€å‘**æ˜¯ä¸€ä¸ªé‡è¦çš„ç›®æ ‡ã€‚**çº³ç±³æŠ€æœ¯æ˜¯åˆ©ç”¨çº³ç±³å­”å’Œçº³ç±³æ¢é’ˆåˆ†æè‚¿ç˜¤ç»†èƒå’Œç—…åŸèŒçš„æ–°å…´æŠ€æœ¯ã€‚ç»“åˆå¾®æµæ§æŠ€æœ¯å’Œå…¶ä»–æµ‹é‡æŠ€æœ¯ï¼Œè¿™äº›æŠ€æœ¯åœ¨æ„å»ºæ›´çµæ•çš„ç”Ÿç‰©ä¼ æ„Ÿå™¨ç³»ç»Ÿä»¥ç­›é€‰æ›´å¤šå¤šæ ·æ€§çš„ä»£è°¢ç‰©æˆ–é…¶ï¼Œè¿›ä¸€æ­¥æé«˜ç­›é€‰æ•ˆç‡æ–¹é¢å…·æœ‰å¾ˆå¤§çš„æ½œåŠ›ã€‚**

 Furthermore, advances in artificial intelligence and the advent of big bio-data are set to revolutionize current screening pipelines and further reduce the costs of HTS.

æ­¤å¤–ï¼Œäººå·¥æ™ºèƒ½çš„è¿›æ­¥å’Œå¤§ç”Ÿç‰©æ•°æ®çš„å‡ºç°å°†å½»åº•æ”¹å˜ç›®å‰çš„ç­›æŸ¥ç®¡é“ï¼Œè¿›ä¸€æ­¥é™ä½HTSçš„æˆæœ¬ã€‚





































#### 7. References

1. [é«˜é€šé‡ç­›é€‰_ç™¾åº¦ç™¾ç§‘ (baidu.com)](https://baike.baidu.com/item/é«˜é€šé‡ç­›é€‰/3940502)
2. [High-throughput screening - Wikipedia (jinzhao.wiki)](https://en.jinzhao.wiki/wiki/High-throughput_screening)
3. Zeng W, Guo L, Xu S, Chen J, Zhou J. High-Throughput Screening Technology in Industrial Biotechnology. Trends Biotechnol. 2020;38(8):888-906. doi:10.1016/j.tibtech.2020.01.001
4. Wong, B., Mancuso, C., Kiriakov, S. *et al.* Precise, automated control of conditions for high-throughput growth of yeast and bacteria with eVOLVER. *Nat Biotechnol* **36,** 614â€“623 (2018).
5. Tan, Z.L. et al. (2019) In vivo continuous evolution of metabolic pathways for chemical production. Microb. Cell Factories 18,82

